Home › Plasmablastic Lymphoma
Plasmablastic Lymphoma clinical trials recruiting in the U.S.
7 studies for Plasmablastic Lymphoma are recruiting participants at sites across the United States.
Cities with the most studies
By state
Recently updated studies
AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07649304A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT04139304HEME-25 Open-Label Feasibility Study of Elranatamab Utilized as Consolidation in Newly Diagnosed Plasmablastic Lymphoma With or Without HIV
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT07647432Testing the Effect of Teclistamab on Recurrent Plasmablastic Lymphoma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT07332507Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Aug 25, 2026 · NCT05389423Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT05663502Study of SGR-1505 in Mature B-Cell Neoplasms
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT05544019From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.